110 related articles for article (PubMed ID: 11363339)
1. The price of life throughout HIV history.
Senak M
J Int Assoc Physicians AIDS Care; 1996 Feb; 2(2):34-5. PubMed ID: 11363339
[TBL] [Abstract][Full Text] [Related]
2. A kinder, gentler ddC... for $7,200 a year.
GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362996
[TBL] [Abstract][Full Text] [Related]
3. Roche submits NDA for Invirase.
J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):37-8. PubMed ID: 11362796
[TBL] [Abstract][Full Text] [Related]
4. Saquinavir (Invirase).
Treat Rev; 1996 Apr; (no 21):5. PubMed ID: 11363396
[TBL] [Abstract][Full Text] [Related]
5. Saquinavir (Invirase): first protease inhibitor approved--reimbursement, information hotline numbers.
James JS
AIDS Treat News; 1995 Dec; (no 237):1-2. PubMed ID: 11363073
[TBL] [Abstract][Full Text] [Related]
6. Saquinavir gets accelerated approval.
McGuire S
Posit Aware; 1996; 7(1):8. PubMed ID: 11363135
[TBL] [Abstract][Full Text] [Related]
7. [New drugs, new obstacles in the fight against HIV].
Fonseca MS
Sidahora; 1996; ():13-4. PubMed ID: 11364289
[TBL] [Abstract][Full Text] [Related]
8. FDA approves nelfinavir. Food and Drug Administration.
GMHC Treat Issues; 1997 Mar; 11(3):8. PubMed ID: 11364277
[TBL] [Abstract][Full Text] [Related]
9. FDA approves 3TC and saquinavir. Food and Drug Administration.
Baker R
BETA; 1995 Dec; ():5, 9. PubMed ID: 11363011
[TBL] [Abstract][Full Text] [Related]
10. Pediatric treatments.
AIDS Policy Law; 1997 Apr; 12(6):12. PubMed ID: 11364179
[TBL] [Abstract][Full Text] [Related]
11. Ritonavir: first to prolong survival.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):38-44. PubMed ID: 11363517
[TBL] [Abstract][Full Text] [Related]
12. New protease inhibitor studies.
Treat Rev; 1995 Nov; (no 20):3. PubMed ID: 11363020
[TBL] [Abstract][Full Text] [Related]
13. Fourth protease inhibitor hits the market.
AIDS Alert; 1997 May; 12(5):59-60. PubMed ID: 11364224
[TBL] [Abstract][Full Text] [Related]
14. New drugs.
Hussar DA
Nursing; 1996 May; 26(5):52-6. PubMed ID: 8710288
[No Abstract] [Full Text] [Related]
15. Lottery opens 2,000 slots for protease trial.
AIDS Alert; 1995 Nov; 10(11):144. PubMed ID: 11362929
[TBL] [Abstract][Full Text] [Related]
16. Why the old saquinavir (Invirase) may be bad for your health.
Vazquez E
Posit Aware; 1997; 8(4):28-31. PubMed ID: 11364485
[TBL] [Abstract][Full Text] [Related]
17. Trial volunteers sought.
Meyer C
Am J Nurs; 1993 May; 93(5):12. PubMed ID: 8488890
[No Abstract] [Full Text] [Related]
18. Saquinavir: newest weapon in the antiviral arsenal.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1996 Feb; 2(2):25-31. PubMed ID: 11363336
[TBL] [Abstract][Full Text] [Related]
19. FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration.
AIDS Treat News; 1995 Oct; (no 233):4-5. PubMed ID: 11363038
[TBL] [Abstract][Full Text] [Related]
20. Saquinavir: combination shows survival benefit; new formulation trial recruiting.
AIDS Treat News; 1996 May; (no 246):1-2. PubMed ID: 11363484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
